Lonza Group AG (LZAGY)
OTCMKTS · Delayed Price · Currency is USD
70.81
+0.38 (0.54%)
Jul 31, 2025, 9:37 AM EDT
Theseus Pharmaceuticals Cash Flow Statement
Financials in millions CHF. Fiscal year is January - December.
Millions CHF. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 733 | 636 | 654 | 1,215 | 2,944 | 869 | Upgrade |
Depreciation & Amortization | 694 | 619 | 593 | 557 | 497 | 505 | Upgrade |
Other Amortization | 180 | 180 | 58 | 45 | 30 | 40 | Upgrade |
Loss (Gain) From Sale of Assets | -72 | -72 | -15 | -201 | -2,228 | 7 | Upgrade |
Asset Writedown & Restructuring Costs | 94 | 94 | 439 | 2 | -7 | 35 | Upgrade |
Loss (Gain) From Sale of Investments | 5 | 5 | 2 | 4 | -27 | 5 | Upgrade |
Loss (Gain) on Equity Investments | 1 | 1 | 13 | -2 | 28 | 8 | Upgrade |
Stock-Based Compensation | 41 | 41 | 21 | 32 | 45 | 48 | Upgrade |
Other Operating Activities | -415 | -107 | -378 | -51 | 213 | -2 | Upgrade |
Change in Accounts Receivable | -108 | -108 | -35 | -252 | -292 | -167 | Upgrade |
Change in Inventory | - | - | 143 | -343 | -381 | -129 | Upgrade |
Change in Accounts Payable | -69 | 3 | -6 | -2 | 213 | -38 | Upgrade |
Change in Other Net Operating Assets | -14 | -95 | -101 | 16 | 182 | -51 | Upgrade |
Operating Cash Flow | 1,147 | 1,274 | 1,388 | 1,020 | 1,217 | 1,130 | Upgrade |
Operating Cash Flow Growth | -24.74% | -8.21% | 36.08% | -16.19% | 7.70% | 15.66% | Upgrade |
Capital Expenditures | -1,431 | -1,381 | -1,648 | -1,826 | -1,301 | -892 | Upgrade |
Sale of Property, Plant & Equipment | - | - | - | - | 3,972 | 29 | Upgrade |
Cash Acquisitions | -1,123 | -1,075 | -93 | -10 | -48 | -15 | Upgrade |
Divestitures | - | - | - | 238 | 120 | 7 | Upgrade |
Sale (Purchase) of Intangibles | -91 | -91 | -49 | -95 | -79 | -98 | Upgrade |
Sale (Purchase) of Real Estate | - | - | -5 | -4 | - | - | Upgrade |
Investment in Securities | 616 | -404 | 662 | 715 | -1,609 | -23 | Upgrade |
Other Investing Activities | 55 | 42 | 53 | 26 | -19 | -6 | Upgrade |
Investing Cash Flow | -1,973 | -2,916 | -1,096 | -974 | 1,021 | -1,089 | Upgrade |
Long-Term Debt Issued | - | 2,071 | 1,348 | - | - | 974 | Upgrade |
Total Debt Issued | 1,112 | 2,071 | 1,348 | - | - | 974 | Upgrade |
Long-Term Debt Repaid | - | -192 | -533 | -212 | -447 | -850 | Upgrade |
Total Debt Repaid | -154 | -192 | -533 | -212 | -447 | -850 | Upgrade |
Net Debt Issued (Repaid) | 958 | 1,879 | 815 | -212 | -447 | 124 | Upgrade |
Issuance of Common Stock | 11 | 9 | 9 | 7 | - | - | Upgrade |
Repurchase of Common Stock | -703 | -726 | -1,020 | -58 | -174 | -141 | Upgrade |
Common Dividends Paid | -280 | -285 | -260 | -223 | -223 | -204 | Upgrade |
Other Financing Activities | 357 | 406 | 304 | 202 | -439 | 314 | Upgrade |
Financing Cash Flow | 343 | 1,283 | -152 | -284 | -1,283 | 93 | Upgrade |
Foreign Exchange Rate Adjustments | -7 | 2 | -11 | -5 | 8 | -20 | Upgrade |
Net Cash Flow | -490 | -357 | 129 | -243 | 963 | 114 | Upgrade |
Free Cash Flow | -284 | -107 | -260 | -806 | -84 | 238 | Upgrade |
Free Cash Flow Growth | - | - | - | - | - | 8.18% | Upgrade |
Free Cash Flow Margin | -4.00% | -1.63% | -3.87% | -12.95% | -1.55% | 5.28% | Upgrade |
Free Cash Flow Per Share | -4.02 | -1.50 | -3.53 | -10.84 | -1.13 | 3.19 | Upgrade |
Cash Interest Paid | 136 | 99 | 80 | 64 | 63 | 49 | Upgrade |
Cash Income Tax Paid | 123 | 136 | 145 | 223 | 166 | 150 | Upgrade |
Levered Free Cash Flow | 10.25 | 69 | 212.63 | -988.25 | 1,079 | -1,118 | Upgrade |
Unlevered Free Cash Flow | 110.75 | 153.88 | 267.13 | -951.13 | 1,125 | -1,077 | Upgrade |
Change in Net Working Capital | 90 | -36 | -447 | 525 | -1,409 | 1,264 | Upgrade |
Updated Jan 29, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.